BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24451073)

  • 1. Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU).
    Depani BP; Naik AA; Nair HA
    Acta Pharm; 2013 Dec; 63(4):479-91. PubMed ID: 24451073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
    Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
    World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
    Radivojša M; Grabnar I; Ahlin Grabnar P
    Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
    Puri R; Jain S
    Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C; Chen D; Gu J; Qin J
    J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.
    Cheng M; Xu H; Wang Y; Chen H; He B; Gao X; Li Y; Han J; Zhang Z
    Drug Des Devel Ther; 2013; 7():1287-99. PubMed ID: 24187487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
    Benito-Miguel M; Blanco MD; Gómez C
    Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil.
    Chen W; Wu Z; Yang H; Guo S; Li D; Cheng L
    Pharm Dev Technol; 2014 Mar; 19(2):223-31. PubMed ID: 23432601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
    Ganguly K; Kulkarni AR; Aminabhavi TM
    Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
    Yan S; Zhu J; Wang Z; Yin J; Zheng Y; Chen X
    Eur J Pharm Biopharm; 2011 Aug; 78(3):336-45. PubMed ID: 21195174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
    Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
    J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer.
    Clares B; Biedma-Ortiz RA; Sáez-Fernández E; Prados JC; Melguizo C; Cabeza L; Ortiz R; Arias JL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):329-38. PubMed ID: 23485475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wheat germ agglutinin-functionalised crosslinked polyelectrolyte microparticles for local colon delivery of 5-FU: in vitro efficacy and in vivo gastrointestinal distribution.
    Glavas-Dodov M; Steffansen B; Crcarevska MS; Geskovski N; Dimchevska S; Kuzmanovska S; Goracinova K
    J Microencapsul; 2013; 30(7):643-56. PubMed ID: 23544879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW; von Borstel R
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.